✦ LIBER ✦

A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer

✍ Scribed by David McLeod; Norman Zinner; Kevin Tomera; Donald Gleason; Nick Fotheringham; Marilyn Campion; Marc B Garnick

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label study of abarelix in men w

✍ Michael Koch; Christopher Steidle; Stanley Brosman; Arthur Centeno; Franklin Gay 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Effectiveness, pharmacokinetics, and saf

✍ Michael Marberger; Amir V Kaisary; Neal D. Shore; Gary S. Karlin; Claudio Savuls 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Open-label, parallel-group, multicenter,

✍ Itzhak Brook; Gerson H. Aronovitz; Michael E. Pichichero 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 570 KB

A six-month, open-label study assessing

✍ Ramon Perez-Marreno; Franklin M. Chu; Donald Gleason; Edward Loizides; Barton Wa 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 835 KB

The efficacy and safety of degarelix: a

✍ Laurence Klotz; Laurent Boccon-Gibod; Neal D. Shore; Cal Andreou; Bo-Eric Persso 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

Eribulin monotherapy versus treatment of

✍ Javier Cortes; Joyce O'Shaughnessy; David Loesch; Joanne L Blum; Linda T Vahdat; 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 392 KB